Espeland MA, Pratley RE, Rosenstock J, Kadowaki T, et al. Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial. Diabetes Obes Metab 2020 Nov 12. doi: 10.1111/dom.14254.
PMID: 33185002